We are live on ! Find out more
FFGM

Founders Fund Growth Management Portfolio holdings

AUM $7.04M
1-Year Est. Return 82.06%
This Fund
S&P 500
This Quarter Est. Return
+29.35%
1 Year Est. Return
-82.06%
3 Year Est. Return
-48.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.13M
AUM Growth
-$31.6M
Cap. Flow
-$34.8M
Cap. Flow %
-3,074.32%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$33.6M
2
ABCL icon
AbCellera Biologics
ABCL
+$1.2M

Sector Composition

Rank Sector Weight
1 Financials 77.93%
2 Real Estate 22.07%
3 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFRM icon
1
Affirm
AFRM
$23.5B
$883K 77.93%
21,624
-1,013,214
-98% -$33.6M
OPEN icon
2
Opendoor
OPEN
$3.69B
$250K 22.07%
129,167
– –
ABCL icon
3
AbCellera Biologics
ABCL
$1.62B
– –
-407,017
Closed -$1.2M

Similar funds

MC
McCarthy & Cox Marysville, Ohio $8.25M AUM 8.7% 1-Year Est. Return
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM

Founders Fund Growth Management's Q3 2024 Portfolio in Review

As of Q3 2024, Founders Fund Growth Management held 3 positions worth $1.13M, down 97% from $32.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund Growth Management withdrew a net $34.8M in Q3 2024, closing 1 position and reducing 1 holding. Its most notable exit was AbCellera Biologics, an estimated $1.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 78% of assets, down from 96% a quarter earlier, followed by Real Estate and Healthcare.

  • Founders Fund Growth Management's biggest Q3 2024 reduction was Affirm, cutting an estimated $33.6M.
  • Founders Fund Growth Management fully exited AbCellera Biologics in Q3 2024, selling an estimated $1.2M.
  • Founders Fund Growth Management's ten largest holdings make up 100% of its $1.13M portfolio in Q3 2024.
  • Founders Fund Growth Management opened 0 new positions and closed 1 in Q3 2024.
  • Founders Fund Growth Management's portfolio value fell 97% quarter-over-quarter to $1.13M.

Based on Founders Fund Growth Management's 13F filing for Q3 2024, filed 14 Nov 2024.